Prestige Brands Holdings

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

PBH reports record fiscal 2023 results, addresses inflation challenges

PBH's strong fiscal 2023 performance was highlighted, but challenges from inflation and foreign currency headwinds were acknowledged. The company is focused on leveraging opportunities for growth and remains committed to its long-term goals.

PBH reports resilient Q1 performance, anticipates high single-digit Q2 growth

PBH's Q1 performance demonstrated resilience with strong sales and margin improvements. While facing challenges in EBITDA and gross margin, the company's strategic focus on brand growth, debt reduction, and share buyback program positions it well for future opportunities. With a reaffirmed full-year outlook and anticipated Q2 growth, PBH remains focused on sustainable growth and financial discipline.

Prestige Brands reports solid Q3 earnings, eyes growth opportunities

Prestige Brands Holdings (PBH) delivered a solid performance in Q3 2023, driven by strong revenue growth, profitability, and strategic financial management.
While facing challenges such as gross margin decline and industry-wide inflationary pressures, the company remains focused on cost management and pricing strategies to sustain growth.
With opportunities for revenue growth, operational efficiency, and strategic planning in fiscal 2024, Prestige Brands is well-positioned for continued success and value creation.

Prestige Brands Holdings reports record fiscal '23 results and outlines growth strategies for fiscal '24

Prestige Brands Holdings delivered strong financial results in fiscal '23, with robust revenue growth and adjusted EPS. The company is focused on maintaining margins, reducing leverage, and capitalizing on growth opportunities in key segments. Management's strategic outlook for fiscal '24 includes revenue projections, EPS targets, and a commitment to disciplined capital allocation.

Prestige Brands Holdings (PBH) surpasses Q1 expectations amidst challenges

PBH's Q1 performance exceeded expectations with strong organic sales growth and improved gross margin despite cost pressures.
While facing challenges from cost increases and debt levels, PBH maintains a solid financial position with strong cash flow.
Opportunities lie in sustained revenue growth, market expansion, and operational efficiency enhancements for PBH in the coming quarters.

Prestige Brands reports robust Q2 results, eyes international growth

Prestige Brands Holdings delivered a solid performance in Q2, driven by strong sales, EPS growth, and debt reduction.
While facing challenges in North America and margin pressure, the company's international growth and e-commerce focus present opportunities for future expansion.
Maintaining a healthy financial position with strong cash flow and reaffirming full-year outlook underscores Prestige Brands' stability and growth potential.
Strategic management of expenses and leveraging brand success will be crucial for sustained growth and profitability in the competitive consumer goods market.

Prestige Brands Holdings reports solid Q3 performance and eyes growth

Prestige Brands Holdings delivered a strong Q3 performance with revenue exceeding expectations and a focus on maintaining market share and brand differentiation.
The company's financial discipline led to debt reduction and healthy free cash flow, while challenges include inventory coverage issues and evaluating M&A opportunities.
Opportunities for growth include exploring potential M&A deals, focusing on long-term financial targets, and capitalizing on international and North American segment growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American and International OTC Healthcare segments manage the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Investors remain optimistic about Prestige Consumer (PBH), backed by the robust strength of its consumer brands portfolio.

Reasons to Buy Prestige Consumer (PBH) Stock for Now

TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine Topical Anesthetic Spray to the consumer level. While benzene is not an ingredient in any Americaine® 20% Benzocaine Topical Anesthetic Spray products, a recent review by our manufacturer and their third-party lab found that a sample from one lot of the product showed a low level of benzene came from the propellant that sprays the product out of the can. Importantly, no other lots of Americaine® 20% Benzocaine Topical Anesthetic Spray (either before or after this batch code) are in the scope of this recall and may continue to be used by consumers safely and as intended.

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene is not an ingredient in any Ting® Antifungal Spray products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. Importantly, no other lots of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder (either before or after these batch codes) and no other Ting® Antifungal Spray products are in the scope of this recall and may continue to be used by consumers safely and as intended.

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

Prestige Consumer's (PBH) long-term brand-building efforts, efficient marketing, channel development and innovation help the company to continually hold a leading market share position.

Prestige Consumer's (PBH) Brand Building, Innovation Aid Growth

Prestige Consumer's (PBH) second-quarter fiscal 2024 results benefit from a diverse brand portfolio and broad distribution.

Prestige Consumer (PBH) Q2 Revenues Top, Margins Expand

While the top- and bottom-line numbers for Prestige Consumer Healthcare (PBH) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's What Key Metrics Tell Us About Prestige Consumer Healthcare (PBH) Q2 Earnings

TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2023.

Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results

TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday, November 2, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Growth Stock

Prestige Consumer (PBH) benefits from a robust healthcare brand portfolio and solid demand.

Prestige Consumer (PBH) Stock Rallies 20% in a Year: Here's Why

Why Prestige Consumer Healthcare (PBH) is a Top Growth Stock for the Long-Term

The heavy selling pressure might have exhausted for Prestige Consumer Healthcare (PBH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Down -11.27% in 4 Weeks, Here's Why You Should You Buy the Dip in Prestige Consumer Healthcare (PBH)

TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 7, 2023 at 3:00 p.m. ET.  All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

Prestige Consumer (PBH) benefits from its solid brand portfolio and favorable demand. E-commerce growth has also been an upside.

Prestige Consumer (PBH) Looks Well-Placed on Brand Strength

Prestige Brands (PBH) possesses solid growth attributes, which could help it handily outperform the market.

Looking for a Growth Stock? 3 Reasons Why Prestige Brands (PBH) is a Solid Choice

Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q1 2024 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Phil Terpolilli - VP, IR and Treasury Ron Lombardi - CEO Christine Sacco - CFO Conference Call Participants Susan Anderson - Canaccord Genuity Rupesh Parikh - Oppenheimer & Co Jon Andersen - William Blair Mitchell Pinheiro - Sturdivant & Co. Operator Good day and thank you for standing by. Welcome to the Q1 2024 Prestige Consumer Healthcare, Inc. Earnings Conference Call.

Prestige Consumer Healthcare Inc. (PBH) Q1 2024 Earnings Call Transcript

The headline numbers for Prestige Brands (PBH) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Prestige Brands (PBH) Reports Q1 Earnings: What Key Metrics Have to Say

Prestige Consumer's (PBH) first-quarter fiscal 2024 results reflect gains from the company's diversified portfolio and brand-building efforts.

Prestige Consumer (PBH) Q1 Earnings Beat Estimates, Decline Y/Y

Prestige Brands (PBH) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.09 per share a year ago.

Prestige Brands (PBH) Tops Q1 Earnings and Revenue Estimates

TARRYTOWN, N.Y., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2023.

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results

Prestige Consumer's (PBH) first-quarter fiscal 2024 earnings are likely to have gained from business strength, brand-building strategies and robust e-commerce business. Rising costs and expenses might have dragged down its margins.

Factors to Note Ahead of Prestige Consumer's (PBH) Q1 Earnings

Lifetime Brands

Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Lifetime Brands (LCUT) and Prestige Brands (PBH). But which of these two stocks is more attractive to value investors?

LCUT vs. PBH: Which Stock Is the Better Value Option?

TARRYTOWN, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 first quarter earnings release on Thursday, August 3, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results

TARRYTOWN, N.Y., July 06, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced the release of its inaugural Environmental, Social, and Corporate Governance (ESG) Sustainability Report. The report highlights the Company's ESG attributes and the steps it has taken to establish baselines to measure the Company's sustainability strategy. The Company's ESG framework is centered on three pillars – supporting an inclusive workforce, responsible corporate citizenship, and producing sustainably.

Prestige Consumer Healthcare Publishes Inaugural Sustainability Report

TARRYTOWN, N.Y., June 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the William Blair Growth Stock Conference in Chicago on Tuesday, June 6, 2023 at 1:00 p.m. ET. The following week, the Company will participate in a fireside chat at the Oppenheimer Consumer Growth & E-Commerce Conference virtually on Monday, June 12, 2023 at 9:45 a.m. ET.

News for Prestige Brands Holdings Stock (PBH)